CME and the NYSE are urging U.S. regulators to regulate Hyperliquid, citing concerns about market manipulation and sanctions circumvention.

CoinFeed reported on May 15 that, according to Bloomberg, the CME Group and the New York Stock Exchange are pushing U.S. regulators to strengthen oversight of Hyperliquid, with key concerns including market manipulation, lack of transparency, and potential sanctions circumvention risks.